Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study. [electronic resource]
- The Journal of infection 01 2020
- 99-110 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-2742
10.1016/j.jinf.2019.09.020 doi
Antiviral Agents--therapeutic use Biomarkers Coinfection--drug therapy HIV Infections--complications Hepatitis C--complications Hepatitis C, Chronic--drug therapy Humans Prospective Studies Ribavirin--therapeutic use